Skip to main content

Table 1 Demographic summary stratified by coronary artery disease status

From: Fully quantitative pixel-wise analysis of cardiovascular magnetic resonance perfusion improves discrimination of dark rim artifact from perfusion defects associated with epicardial coronary stenosis

  NonCAD (N = 55) CAD (N = 21) p-value
Cardiovascular Risk Factors
 Age 53.0 ± 11.7 63.0 ± 10.1 0.001
 Male 29 53% 15 71% 0.195
 Hypertension 26 47% 14 67% 0.199
 Hyperlipidemia 26 47% 18 86% 0.004
 Diabetes 5 9% 5 24% 0.128
 Smoking 21 38% 12 57% 0.196
 Family history of CAD 14 25% 10 48% 0.097
 Body mass index (kg/m2) 29.1 ± 6.6 28.3 ± 4.6 0.81
Past Medical History
 Prior PCI 0 0% 3 14% 0.019
 CABGa 0 0% 0 0% 1.000
 Prior cerebrovascular accident 0 0% 1 5% 0.276
Medications
 Aspirin or Anti-Platelet 29 53% 15 71% 0.25
 Beta blocker 19 35% 11 52% 0.27
 Calcium channel blocker 4 7% 1 5% 0.84
 Nitrate 2 4% 1 5% 0.65
 Diuretic 8 15% 2 19% 0.94
 ACE inhibitor 13 24% 8 38% 0.35
 ARB 4 7% 2 10% 0.97
 Statin 22 40% 19 90% < 0.001
  1. Abbreviations: ACE angiotensin converting enzyme inhibitor, ARB angiotensin receptor blocker, BP blood pressure, CABG coronary artery bypass grafting, CAD coronary artery disease, LV left ventricular, LVEDV left ventricular end diastolic volume, LVESV left ventricular end systolic volume, LVEDMass left ventricular end diastolic mass, LGE late gadolinium enhancement, N/A not applicable, PCI percutaneous coronary intervention
  2. p values that were significant (p<0.050 or lower) are in bold
  3. aPatients with a prior history of coronary artery by-pass surgery and 3 vessel CAD were excluded from this study